Fabio Cataldi - 28 Feb 2023 Form 4 Insider Report for Landos Biopharma, Inc.

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LABP	Employee Stock Option (right to buy)	Award	$0	+184,500		$0.000000	184,500	28 Feb 2023	Common Stock	184,500	$0.3700	Direct	F1
transaction	LABP	Restricted Stock Unit	Award	$0	+276,750		$0.000000	276,750	28 Feb 2023	Common Stock	276,750		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	1/4th of the shares initially subject to the option shall vest on the one (1) year anniversary of the date of grant (such anniversary being the "Anniversary Date") and 1/48th of the shares initially subject to the option shall vest on each monthly anniversary of the Anniversary Date thereafter, subject to the Reporting Person's continuous service with the Issuer on each such date.
F2	Each restricted stock unit represents the right to receive one share of Landos Biopharma, Inc., Inc. common stock.
F3	The Restricted Stock Unit ("RSU") shall vest as to 66 2/3% of the shares underlying the RSU on the second anniversary of the date of grant and shall vest as to 33 1/3% of the shares underlying the RSU on the third anniversary of the date of grant, subject to the Reporting Person's continuous service with the Issuer on each such date.